Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Mirati Therapeutics, Inc. - Common Stock (NQ:MRTX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 22, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	58.85 (1)
Ask (Size)	59.74 (10)
Prev. Close	58.70
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	51,623,193
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

December 20, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Performance

More News

Analyst Expectations For Mirati Therapeutics's Future ↗

December 20, 2023

Via Benzinga

Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment

November 29, 2023

Via FinancialNewsMedia

What 11 Analyst Ratings Have To Say About Mirati Therapeutics ↗

November 07, 2023

Via Benzinga

3 Resilient Stocks with Massive Potential to Boost Your Wealth ↗

November 26, 2023

Via InvestorPlace

These Three Biotech Stocks Are Trading At A Discount ↗

November 23, 2023

Via Talk Markets

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 17, 2023

Via Benzinga

3 Biotech Stocks That Could Boom or Bust by 2025 ↗

November 16, 2023

Via InvestorPlace

MIRATI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX

November 08, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

3 No-Brainer Stocks to Buy With $500 Right Now ↗

November 08, 2023

Via The Motley Fool

Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 07, 2023

Via Benzinga

Is MIRATI THERAPEUTICS INC Ready to Break Out of Its Range? ↗

November 06, 2023

Via Chartmill

7 Healthcare Stocks That Can Cure a Lackluster Portfolio ↗

October 19, 2023

Via InvestorPlace

Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings ↗

October 19, 2023

Via Benzinga

Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race

October 17, 2023

Via PressReach

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq – CNSL), Mirati Therapeutics, Inc.® (Nasdaq - MRTX), Pioneer Natural Resources (NYSE - PXD), Summit Materials (NYSE

October 16, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Amgen Stock Surges To 10-Month High, Up 4% On An Unexpected Upgrade ↗

October 11, 2023

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 ↗

October 10, 2023

Via Benzinga

Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

October 10, 2023

Via PressReach

MIRATI THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mirati Therapeutics, Inc. - MRTX

October 09, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 09, 2023

Via Benzinga

Why Shares of Tango Therapeutics Are Dropping Monday ↗

October 09, 2023

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023 ↗

October 09, 2023

Via Benzinga

Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 09, 2023

Via Benzinga

Frequently Asked Questions

Is Mirati Therapeutics, Inc. - Common Stock publicly traded?

Yes, Mirati Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Mirati Therapeutics, Inc. - Common Stock trade on?

Mirati Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Mirati Therapeutics, Inc. - Common Stock?

The ticker symbol for Mirati Therapeutics, Inc. - Common Stock is MRTX on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.